Viewing Study NCT01239732


Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2025-12-25 @ 7:38 PM
Study NCT ID: NCT01239732
Status: COMPLETED
Last Update Posted: 2016-06-10
First Post: 2010-11-10
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Sponsor: Hoffmann-La Roche
Organization: